Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Cryo-Cell International (CCEL) Earnings Date, Estimates & Call Transcripts

$6.82
+0.65 (+10.53%)
(As of 09/20/2024 ET)

Earnings Summary

Latest
Earnings Date
Jul. 15Estimated
Actual EPS
(Jul. 15)
$0.08 Beat By $0.04
Consensus EPS
(Jul. 15)
$0.04
Skip Charts & View Estimated and Actual Earnings Data

CCEL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CCEL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CCEL Earnings Date and Information

Cryo-Cell International last released its quarterly earnings results on July 15th, 2024. The reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.04. The business earned $8.04 million during the quarter. Cryo-Cell International has generated ($1.16) earnings per share over the last year (($1.16) diluted earnings per share).

Cryo-Cell International Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
7/15/2024Q2 2024$0.04$0.08+$0.04$0.08-$8.04 million
4/15/2024Q1 2024-$0.07+$0.07$0.07-$7.85 million
2/28/2024Q4 2023-$0.26+$0.26$1.86-$7.88 million
10/12/2023Q3 2023($0.05)$0.08+$0.13$0.08-$7.87 million
7/14/2023Q2 2023($0.07)$0.03+$0.10$0.03-$7.77 million
4/21/2023Q1 2023-$0.09+$0.09$0.09-$7.82 million
Is Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.
2/28/2023Q4 2022-$0.10+$0.10$0.10-$7.76 million
10/14/2022Q3 2022-$0.06+$0.06$0.06-$7.70 million
7/11/2022Q2 2022-$0.07+$0.07$0.07-$7.63 million
4/13/2022Q1 2022-$0.10+$0.10$0.10-$7.26 million
2/22/2022Q4 2021-($0.08)($0.08)($0.08)-$7.32 million
10/15/2021Q3 2021-$0.10+$0.10$0.10-$7.50 million
7/15/2021Q2 2021-$0.14+$0.14$0.14-$7.21 million
4/14/2021Q1 2021-$0.08+$0.08$0.08-$6.86 million
2/24/2021Q4 2020-$0.15+$0.15$0.15-$7.49 million
10/15/2020Q3 2020-$0.10+$0.10$0.10-$8.10 million
7/10/2020Q2 2020-$0.12+$0.12$0.12-$7.87 million
4/14/2020Q1 2020-$0.07+$0.07$0.06-$7.62 million
2/27/2020Q4 2019-$0.10+$0.10$0.10-$7.95 million
10/15/2019Q3 2019-$0.13+$0.13$0.13-$8.20 million

Cryo-Cell International Earnings - Frequently Asked Questions

When did Cryo-Cell International announce their last quarterly earnings?

Cryo-Cell International (NYSEAMERICAN:CCEL) last announced its quarterly earning data on Monday, July 15, 2024. Learn more on CCEL's earnings history.

Did Cryo-Cell International beat their earnings estimates last quarter?

In the previous quarter, Cryo-Cell International (NYSEAMERICAN:CCEL) reported $0.08 earnings per share (EPS) to beat the analysts' consensus estimate of $0.04 by $0.04. Learn more on analysts' earnings estimate vs. CCEL's actual earnings.

How much revenue does Cryo-Cell International generate each year?

Cryo-Cell International (NYSEAMERICAN:CCEL) has a recorded annual revenue of $31.34 million.

How much profit does Cryo-Cell International generate each year?

Cryo-Cell International (NYSEAMERICAN:CCEL) has a recorded net income of -$9.52 million. CCEL has generated -$1.16 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat


This page (NYSEAMERICAN:CCEL) was last updated on 9/21/2024 by MarketBeat.com Staff
From Our Partners